Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details)

v3.19.3
Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Payables And Accruals [Abstract]    
Clinical trial and related costs $ 101 $ 683
Professional and consulting fees 1,012 671
Payroll and related costs 1,753 2,172
Accrued restructuring costs 1,386  
Property, plant and equipment   278
Pre-commercialization scale-up costs   4,445
Other research and development costs 136 678
Other 112 846
Total accrued expenses and other current liabilities $ 4,500 $ 9,773